HEMOGLOBINOPATHIES
Tracking # 20-411041
$99999.00
There are no ratings for this course
Course overview
The hemoglobinopathies are a heterogeneous group of autosomal-recessive disorders characterized by abnormal synthesis or structure of the oxygen-carrying Hgb molecule in RBCs. Sickle cell disease (SCD) and the thalassemias are the most common hemoglobinopathies. Hemoglobinopathies are suspected based on family history and clinical manifestations; blood tests demonstrating abnormal Hgb confirm the diagnosis. Treatment goals include symptom control and management of disease complications. This continuing education module is designed to give the reader/learner an increased understanding of hemoglobinopathies, including its clinical presentation, symptoms, and treatment, and to aid in caring for the patient with this diagnosis. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.
Subject areas
This course counts toward the state boards and subject areas below.